July 22, 2020

Clinical Efficacy of Convalescent Plasma for Treatment of COVID-19 Infections: Results of a Multicenter Clinical Study

Category: Article Summary

Topic: Testing and Treatment

• A prospective cohort study (n=189) of COVID-19 patient in Iran showed that compared to the control group, participants receiving convalescent plasma therapy (n=115) had a significantly higher proportion of hospital discharge (98% vs 79%), shorter mean length of hospitalization (9.5 days vs 12.9 days), and lower proportion requiring intubation (7% vs 20%). 

Abolghasemi et al. (July 6, 2020). Clinical Efficacy of Convalescent Plasma for Treatment of COVID-19 Infections: Results of a Multicenter Clinical Study. Transfusion and Apheresis Science. https://doi.org/10.1016/j.transci.2020.102875